Delta 9 Cannabis - CEO, John Arbuthnot.
CEO, John Arbuthnot.
Source: Delta 9 Cannabis.
  • Delta 9 Cannabis (DN) has obtained a $4,990,264.37 loan from a shareholder due on July 15, 2025
  • The loan shall bear interest at 6 per cent per annum, payable monthly
  • Delta 9 Cannabis is a vertically integrated cannabis company
  • Delta 9 Cannabis Inc. (DN) is unchanged on the day, trading at C$0.295 per share at 1:45 pm ET

Delta 9 Cannabis (DN) has obtained a $4,990,264.37 loan from a shareholder due on July 15, 2025.

The loan shall bear interest at 6 per cent per annum, payable monthly.

Delta 9 Cannabis Inc. is a cannabis company focused on bringing high-quality cannabis products to market.

Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba.

Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand.

Delta 9 Cannabis Inc. (DN) is unchanged on the day, trading at C$0.295 per share at 1:45 pm ET.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.